Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Andrew D Zelenetz Peter G Maslak Katherine S Panageas |
| Publication date | March 6, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |